Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups

Venture firms still sound like they learned conviction from a branding agency and risk tolerance from a podcast sponsor. Restive Ventures walks into the room like people who actually survived a few market cycles and kept the receipts. Now Restive Ventures closes Restive Fund III at $45M, and the signal underneath the headline matters more than the headline itself.

Ryan Falvey and Tyler Griffin have been building this thing since 2018, back when fintech was still getting dressed up like a disruptor while half the industry was really just PDF forms wearing skinny jeans. Restive saw the deeper current early. Financial services was never going to be “digitized” by prettier interfaces alone. The real shift was infrastructure, intelligence, workflow, compliance, and eventually AI sitting inside the bloodstream of money itself.

Restive stayed focused while the market spent a few years acting like every startup with a dashboard and a debit card deserved a parade. Now the noise is thinning out, and disciplined specialists suddenly look real attractive again. Funny how that works. Wall Street discovers fundamentals every few cycles like a suburban dad suddenly pretending he always understood wine.

Fund III doubles down on AI-native financial services, and that phrase carries weight if you actually understand what’s happening underneath the hood. We’re talking about software that reasons through workflows, underwrites faster, detects fraud smarter, and compresses operational drag. The pipes are getting intelligent now. That’s where Cameron Peake and the broader Restive team have been leaning in. Small. Concentrated. Early. Helpful. That’s portfolio construction with intention.

Restive is still behaving like builders. You can see it in the structure. Tom Brown as Venture Advisor. Ben Glenney in the trenches as Associate. The firm looks engineered for proximity to founders, not distance from them. That matters when markets tighten and everyone suddenly remembers that execution is a blood sport.

The numbers already tell a serious story. 50 companies backed. Strong follow-on outcomes. 1 IPO. Multiple acquisitions. Several billion in enterprise value created. But the bigger takeaway sits somewhere else. Focus is becoming the premium product in venture capital. Not access. Not branding. Not conference-panel theater delivered by people wearing loafers with no socks while explaining “community.” Focus. Real domain obsession that survives hype cycles, rate shocks, and AI hysteria without losing its center.

Fund III feels less like a victory lap and more like a pressure test for where fintech capital is heading next. Generalist firms can chase trends. Restive is betting that AI-native financial services becomes infrastructure, not fashion. One plays for headlines. The other plays for permanence.